Progress towards a vaccine for nontypable Haemophilus influenzae

Annals of Medicine

Volumn 28, Issue 1, 1996, Pages 31-37

  St Geme III, Joseph W ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bacterial antigens; Nontypable Haemophilus influenzae; Prevention; Vaccine

Indexed keywords

ANTIBIOTIC AGENT; BACTERIAL ANTIGEN; HAEMOPHILUS INFLUENZAE VACCINE;

GRAM NEGATIVE INFECTION; HAEMOPHILUS INFLUENZAE; HUMAN; INFECTION PREVENTION; MORBIDITY; PRIORITY JOURNAL; REVIEW; VACCINATION;

EID: 0030038220     PISSN: 07853890     EISSN: None     Source Type: Journal    
DOI: 10.3109/07853899608999071     Document Type: Review

References (64)

1. Ward J, Lieberman JM, Cochi SL. Haemophilus influenzae vaccines. In: Plotkin SA, Mortimer EA, eds. Vaccines. 2nd edn. Philadelphia: WB Saunders, 1994.
2. Kuklinska D, Kilian M. Relative proportions of Haemophilus species in the throat of healthy children and adults. Eur J Clin Microbiol 1984; 3: 249-52.
3. Howard AJ, Dunkin KT, Millar GW. Nasopharyngeal carriage and antibiotic resistance of Haemophilus influenzae in healthy children. Epidemiol Infect 1988; 100: 192-203.
4. Spinola SM, Peacock J, Denny FW, Smith DL, Cannon JG. Epidemiology of colonization by nontypable Haemophilus influenzae in children: a longitudinal study. J Infect Dis 1986; 154: 100-9.
5. Trottier S, Stenberg K, Svanborg-Eden C. Turnover of nontypable Haemophilus influenzae in the nasopharynges of healthy children. J Clin Microbiol 1989; 27: 2175-9.
6. St. Geme JW III. Nontypeable Haemophilus influenzae disease: epidemiology, pathogenesis, and prospects for prevention. Infect Agents Dis 1993; 2: 1-16.
7. Giebink GS. The microbiology of otitis media. Pediatr Infect Dis J 1989; 8: S18-S20.
8. Riding KH, Bluestone CD, Michaels RH, Cantekin EI, Doyle WJ, Poziviak CS. Microbiology of recurrent and chronic otitis media with effusion. J Pediatr 1978; 93: 739-43.
9. Evans FO, Sydnor JB, Moore WEC, et al. Sinusitis of the maxillary antrum. N Engl J Med 1975; 293: 735-9.
10. Wald ER, Milmore GJ, Bowen A, Ledesma-Medina J, Salamon N, Bluestone CD. Acute maxillary sinusitis in children. N Engl J Med 1981; 304: 749-54.
11. Murphy TF, Apicella MA. Nontypable Haemophilus influenzae: a review of clinical aspects, surface antigens, and the human immune response to infection. Rev Infect Dis 1987; 9: 1-15.
12. Shann F. Etiology of severe pneumonia in children in developing countries. Pediatr Infect Dis 1986; 5: 247-52.
13. Murphy TF, Sethi S. Bacterial infection in chronic obstructive pulmonary disease. Am Rev Respir Dis 1992; 146: 1067-83.
14. Barry AL, Phaller MA, Fuchs PC, Packer RR. In vitro activities of 12 orally administered agents against four species of bacterial respiratory pathogens from US medical centers in 1992 and 1993. Antimicrob Agents Chemother 1994; 38: 2419-25.
15. Pichichero ME, Pichichero CL. Persistent acute otitis media. I. Causative pathogens. Pediatr Infect Dis J 1995; 14: 178-83.
16. Mendelman PM, Smith AL. Haemophilus influenzae. In: Feigin RD, Cherry JD, eds. Textbook of Pediatric Infectious Diseases, 3rd edn. Philadelphia: WB Saunders, 1992.
17. Teele DW, Klein JO, Chase C, Menyuk P, Rosner B, and the Greater Boston Otitis Media Study Group. Otitis media in infancy and intellectual ability, school achievement, speech, and language at age 7 years. J Infect Dis 1990; 162: 685-94.
18. Stool SE, Field MJ. The impact of otitis media. Pediatr Infect Dis J 1989; 8: S11-4.
19. Monto AS. Acute respiratory infection in children of developing countries: challenge of the 1990s. Rev Infect Dis 1989; 11: 498-505.
20. Musser JM, Barenkamp SJ, Granoff DM, Selander RK. Genetic relationships of serologically nontypeable and serotype b strains of Haemophilus influenzae. Infect Immun 1986; 52: 183-91.
21. Sloyer JL, Cate CC, Howie VM, Ploussard JH, Johnston RB Jr. The immune response to acute otitis media in children. II. Serum and middle ear fluid antibody in otitis media due to Haemophilus influenzae. J Infect Dis 1975; 132: 685-8.
22. Faden H, Brodsky L, Bernstein J, et al. Otitis media in children: local immune response to nontypeable Haemophilus influenzae. Infect Immun 1989; 57: 3555-9.
23. Karasic RB, Trumpp CE, Gnehm HE, Rice PA, Pelton SI. Modification of otitis media in chinchillas rechallenged with nontypable Haemophilus influenzae and serological response to outer membrane antigens. J Infect Dis 1985; 151: 273-9.
24. Faden H, Bernstein J, Brodsky L, et al. Otitis media in children. I. The systemic immune response to nontypable Haemophilus influenzae. J Infect Dis 1989; 160: 999-1004.
25. Musher DM, Hague-Park M, Baughn RE, Wallace RJ Jr, Cowley B. Opsonizing and bactericidal effects of normal human serum on nontypable Haemophilus influenzae. Infect Immun 1983; 39: 297-304.
26. Gnehm HE, Pelton SI, Gulati S, Rice PA. Characterization of antigens from nontypable Haemophilus influenzae recognized by human bactericidal antibodies. J Clin Invest 1985; 75: 1645-57.
27. Barenkamp SJ. Protection by serum antibodies in experimental nontypable Haemophilus influenzae otitis media. Infect Immun 1986; 52: 572-8.
28. Nelson MB, Munson RS Jr, Apicella MA, Sikkema DJ, Molleston JP, Murphy TF. Molecular conservation of the P6 outer membrane protein among strains of Haemophilus influenzae: analysis of antigenic determinants, gene sequences, and restriction fragment, length polymorphisms. Infect Immun 1991; 8: 2658-63.
29. Murphy TF, Nelson MB, Dudas KC, Mylotte JM, Apicella MA. Identification of a specific epitope of Haemophilus influenzae on a 16,000-dalton outer membrane protein. J Infect Dis 1986; 152: 1300-7.
30. Murphy TF, Bartos LC, Rice PA, Nelson MB, Dudas KC, Apicella MA. Identification of a 16,600-dalton outer membrane protein on nontypeable Haemophilus influenzae as a target for human serum bactericidal antibody. J Clin Invest 1986; 78: 1020-7.
31. Munson RS Jr, Granoff DM. Purification and partial characterization of outer membrane proteins P5 and P6 from Haemophilus influenzae type b. Infect Immun 1985; 49: 544-9.
32. DeMaria TF, Billy J, Leake E. Immunization with outer membrane protein P6 from nontypable Haemophilus influenzae (NTHi) induces bactericidal antibody and affords protection in the chinchilla model of otitis media. Abstracts of the 95th General Meeting of the American Society for Microbiology 1995: 193.
33. Yamanaka N, Faden H. Antibody response to outer membrane protein of nontypeable Haemophilus influenzae in otitis-prohe children. J Pediatr 1993; 122: 212-8.
34. Green BA, Farley JE, Quinn-Dey T, Deich RA, Ziotnick GW. The e (P4) outer membrane protein of Haemophilus influenzae: biologic activity of anti-e serum and cloning and sequencing of the structural gene. Infect Immun 1991; 59: 3191-8.
35. Deich RA, Metcalf BJ, Finn CW, Farley JE, Green BA. Cloning of genes encoding a 15,000-dalton peptidoglycan-associated outer membrane lipoprotein and an antigenically related 15,000-dalton protein from Haemophilus influenzae. J Bacteriol 1988; 170: 489-98.
36. Deich RA, Anilionis A, Fulginiti J, et al. Antigenic conservation of the 15,000-dalton outer membrane lipoprotein PCP of Haemophilus influenzae and biologic activity of anti-PCP antisera. Infect Immun 1990; 58: 3388-93.
37. Brinton CC Jr, Carter MJ, Derber DB, et al. Design and development of pilus vaccines for Haemophilus influenzae diseases. Pediatr Infect Dis J 1989; 8: S54-61.
38. van Alphen L, Poole J, Overbeeke M. The Anton blood group antigen is the erythrocyte receptor for Haemophilus influenzae. FEMS Microbiol Lett 1986; 37: 69-71.
39. Guerina NG, Langermann S, Clegg HW, Kessler HW, Goldmann DA, Gilsdorf JR. Adherence of piliated Haemophilus influenzae type b to human oropharyngeal cells. J Infect Dis 1982; 146: 564.
40. Pichichero ME, Anderson P, Loeb M, Smith DH. Do pili play a role in pathogenicity of Haemophilus influenzae type b? Lancet 1982; ii: 960-2.
41. van Ham SM, van Alphen L, Mooi FR, van Putten JP. The fimbrial gene cluster of Haemophilus influenzae type b. Mol Microbiol 1994; 13: 673-84.
42. McCrea KW, Watson WJ, Gilsdorf JR, Marrs CF. Identification of hifD and hifE in the pilus gene cluster of Haemophilus influenzae type b strain Eagan. Infect Immun 1994; 62: 4922-8.
43. 43: Gilsdorf JR, Chang HY, McCrea KW, Bakaletz LO. Comparison of hemagglutinating pili of Haemophilus influenzae type b with similar structures of nontypeable H influenzae. Infect Immun 1992; 60: 374-9.
44. Gilsdorf JR, McCrea K, Forney L. Conserved and nonconserved epitopes among Haemophilus influenzae type b pili. Infect Immun 1990; 58: 2252-7.
45. Karasic RB, Beste DJ, To SC-M, et al. Evaluation of pilus vaccines for prevention of experimental otitis media caused by nontypable Haemophilus influenzae. Pediatr Infect Dis J 1989; 8: S62-5.
46. van Alphen LL, Geelen-van den Broek L, Blaas L, van Ham M, Dankert J. Blocking of fimbria-mediated adherence of Haemophilus influenzae by sialyl ganglio-sides. Infect Immun 1991; 59: 4473-7.
47. Shurin PA, Pelton SI, Tager IB, Kasper DL. Bactericidal antibody and susceptibility to otitis media caused by nontypable strains of Haemophilus influenzae. J Pediatr 1980; 97: 364-9.
48. Barenkamp SJ, Bodor FF. Development of serum bactericidal activity following nontypable Haemophilus influenzas acute otitis media. Pediatr Infect Dis J 1990; 9: 333-9.
49. Barenkamp SJ, Leininger E. Cloning, expression, and DNA sequence analysis of genes encoding nontypeable Haemophilus influenzae high molecular weight surface-exposed proteins related to filamentous hemagglutinin of Bordetella pertussis. Infect Immun 1992; 60: 1302-13.
50. St. Geme JW III, Falkow S, Barenkamp SJ. High-molecular-weight proteins of nontypable Haemophilus influenzae mediate attachment to human epithelial cells. Proc Natl Acad Sci USA 1993; 90: 2875-9.
51. Barenkamp SJ, St. Geme JW III. Identification of surface-exposed B-cell epitopes on high molecular weight (HMW) adhesion proteins of nontypable Haemophilus influenzae (NTHI). Pediatr Res 1994; 35: 174 A.
52. Barenkamp SJ. Immunization with high molecular weight (HMW) proteins protects chinchillas against experimental nontypable Haemophilus influenzae (NTHI) otitis media (OM). Pediatr Res 1993; 33: 162 A.
53. Barenkamp SJ, St. Geme JW III. Identification of a second family of high-molecular-weight adhesion proteins expressed by nontypable Haemophilus influenzae. Mol Microbiol (in press).
54. Thomas WR, Callow MG, Dilworth RJ, Audesho AA. Expression in Escherichia coli of a high-molecular-weight protective surface antigen found in nontypeable and type b Haemophilus influenzae. Infect Immun 1990; 58: 1909-13.
55. Cope LD, Thomas SE, Latimer JL, Slaughter CA, Muller-Eberhard U, Hansen EJ. The 100 kDa haem:haemopexin-binding protein of Haemophilus influenzae: structure and localization. Mol Microbiol 1994; 13: 863-73.
56. Gulig PA, McCracken GH Jr, Holmans PL, Hansen EJ. Immunogenic proteins in cell-free culture supernatants of Haemophilus influenzae type b. Infect Immun 1984; 44: 41-8.
57. Gray-Owen SD, Loosmore S, Schryvers AB. Identification and characterization of genes encoding the human transferrin-binding proteins from Haemophilus influenzae. Infect Immun 1995; 63: 1201-10.
58. St. Geme JW III, de la Morena ML, Falkow S. A Haemophilus influenzae IgA protease-like protein promotes intimate interaction with human epithelial cells. Mol Microbiol 1994; 14: 217-33.
59. Sirakova T, Kolattukudy PE, Murwin D, et al. Role of fimbriae expressed by nontypeable Haemophilus influenzae in pathogenesis of and protection against otitis media and relatedness of the fimbrin subunit to outer membrane protein A. Infect Immun 1994; 62: 2002-18.
60. McGhee JR, Mestecky J, Dertzbaugh MT, Eldridge JH, Hirasawa M, Kiyono H. The mucosal immune system: from fundamental concepts to vaccine development. Vaccine 1992; 10: 75-88.
61. Elson CO. Cholera toxin and its subunits as potential oral adjuvants. Curr Top Microbiol Immunol 1989; 146: 29-33.
62. Curtiss R III, Kelly XM, Gulig PA, Nakayama K. Selective delivery of antigens by recombinant bacteria. Curr Top Microbiol Immunol 1989; 146: 35-49.
63. Eldridge JH, Gilley RM, Staas JK, Moldoveanu Z, Meulbroek JA, Tice TR. Biodegradable microspheres: vaccine delivery system for oral immunization. Curr Top Microbiol Immunol 1989; 146: 59-66.
64. Haq TA, Mason HS, Clements JD, Arntzen CJ. Oral immunization with a recombinant bacterial antigen produced in transgenic plants. Science 1995; 268: 714-5.